Medigraph (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 21-05-2024
- Paid Up Capital ₹ 3.37 M
as on 21-05-2024
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 8.33%
(FY 2017)
- Profit -27.02%
(FY 2017)
- Ebitda -19.25%
(FY 2017)
- Net Worth -1.13%
(FY 2017)
- Total Assets -0.39%
(FY 2017)
About Medigraph (India)
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.37 M, as per Ministry of Corporate Affairs (MCA) records.
Pranay Goel and Anjalee Goel serve as directors at the Company.
- CIN/LLPIN
U33100MH1992PTC065262
- Company No.
065262
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Medigraph (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pranay Goel  | Director | 06-Feb-1992 | Current |
| Anjalee Goel | Director | 02-Apr-1995 | Current |
Financial Performance of Medigraph (India).
Medigraph (India) Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 8.33% increase. The company also saw a substantial fall in profitability, with a 27.02% decrease in profit. The company's net worth dipped by a decrease of 1.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medigraph (India)?
In 2017, Medigraph (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anrisa Estates Private LimitedActive 3 years 5 monthsPranay Goel and Anjalee Goel are mutual person
- Fairdeal Diamond Private LimitedActive 14 years 2 months
Pranay Goel and Anjalee Goel are mutual person
- Nupran Trade And Investment Private LimitedActive 42 years 1 month
Pranay Goel and Anjalee Goel are mutual person
- Taragen Investments Private LimitedActive 30 years 9 months
Pranay Goel and Anjalee Goel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medigraph (India)?
Unlock and access historical data on people associated with Medigraph (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medigraph (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medigraph (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
